4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:原厂直采,平行进口,授权代理(蚂蚁淘为您服务)
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > primary_antibodies > Abnova/FFPE鱼类预处理套件1/1kit/KA2375
商品详细Abnova/FFPE鱼类预处理套件1/1kit/KA2375
Abnova/FFPE鱼类预处理套件1/1kit/KA2375
Abnova/FFPE鱼类预处理套件1/1kit/KA2375
商品编号: KA2375
品牌: abnovadx
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 一抗
公司分类: primary_antibodies
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
  • Specification
  • Product Description:
  • Pre-treatment is an essential step for effective FISH on Formalin-Fixed Paraffin-Embedded (FFPE) tissue sections. This kit contains key reagents used to pretreat FFPE tissue sections from dewaxing with xylene through proteolytic digestion to helps permeabilization of cell membranes to facilitate penetration of fluorescence labeled probes. After proteolytic digestion, proceed the subsequent steps with the FISH assay protocol.
  • Supplied Product:
  • Kit content:1. 1x Paraffin Pretreatment Solution, 500 mL2. Protease (Pepsin), 0.5 mL x 10 vials
  • Storage Instruction:
  • After arrival, please store the Paraffin Pretreatment Solution at room temperature (RT), and store the Protease (Pepsin) at -20°C.
  • Protocol:
  • PDF DownloadProtocol Download
  • MSDS:
  • PDF DownloadDownload
  • Regulation Status:
  • For research use only (RUO)
  • Datasheet:
  • PDF DownloadDownload
  • Publication Reference
  • 1.
  • Deficiency of PTEN and CDKN2A Tumor-Suppressor Genes in Conventional and Chondroid Chordomas: Molecular Characteristics and Clinical Relevance.Chenlong Yang, Jianjun Sun, Lei Yong, Chen Liang, Tie Liu, Yulun Xu, Jun Yang, Xiaoguang Liu.Onco Targets Ther. 2020 May 25;13:4649-4663. doi: 10.2147/OTT.S252990. eCollection 2020.
  • 2.
  • Clinical significance of PD-1/PD-Ls gene amplification and overexpression in patients with hepatocellular carcinoma.Ma LJ, Feng FL, Dong LQ, Zhang Z, Duan M, Liu LZ, Shi JY, Yang LX, Wang ZC, Zhang S, Ding ZB, Ke AW, Cao Y, Zhang XM, Zhou J, Fan J, Wang XY, Gao Q.Theranostics. 2018 Nov 10;8(20):5690-5702. doi: 10.7150/thno.28742. eCollection 2018.
  • 3.
  • FGF19 genetic amplification as a potential therapeutic target in lung squamous cell carcinomas.Zhang X, Kong M, Zhang Z, Xu S, Yan F, Wei L, Zhou J.Thorac Cancer. 2017 Sep 14. [Epub ahead of print]
  • 4.
  • Investigation of Molecular Alterations of AKT-3 in Triple Negative Breast Cancer.O"Hurley G, Daly E, O"Grady A, Cummins R, Quinn C, Flanagan L, Pierce A, Fan Y, Lynn MA, Rafferty M, Fitzgerald D, Pont幯 F, Duffy MJ, Jirstr闣 K, Kay EW, Gallagher WM.Histopathology. 2013 Oct 19. doi: 10.1111/his.12313.
  • Applications
  • Fluorescent In Situ Hybridization (Cell)
  • PDF DownloadProtocol Download
  • Application Image
  • Fluorescent In Situ Hybridization (Cell)
品牌介绍
Abnova是世界上最大的抗体制造商。亚诺法的所有产品,重组蛋白和抗体都是利用最新的技术及由SPF等级动物实验室制造生产出来。我们的目标是生产人类基因组内每个基因至少要有一个相对应的抗体,可以提供给来自于学术机构、行业的伙伴和合作者做研究。亚诺法有许多多样化的单克隆及多克隆抗体,我们更进一步开发一系列的整合系统与相关应用包含配对抗体、ELISA试剂盒与荧光原位杂交(FISH)探针。这些工具对生物标记开发与转译研究都是必须的。亚诺法亦有针对糖尿病、传染疾病与癌症的体外检验试剂专案以及用于治疗败血症的全人类抗体药技专案,为全人类的健康努力。